Novartis (NVS)
(Delayed Data from NYSE)
$115.30 USD
+1.56 (1.37%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $115.07 -0.23 (-0.20%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
NVS 115.30 +1.56(1.37%)
Will NVS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for NVS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NVS
ALNY Q2 Earnings Top Estimates on Higher Amvuttra Revenues, Stock Up
Ionis Beats on Q2 Earnings & Sales, Stock Up 5% on Raised '25 Outlook
NVS: What are Zacks experts saying now?
Zacks Private Portfolio Services
INCY's Q2 Earnings & Revenues Beat Estimates on Higher Product Sales
Incyte Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
Here's Why Novartis (NVS) is a Strong Value Stock
Other News for NVS
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Private Markets: Scale rival Surge AI in talks for funding at $25B value
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
Market Today: Amazon (AMZN) and Apple (AAPL) Lead Earnings Surge